Filing Details
- Accession Number:
- 0001181431-13-049523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-17 17:37:03
- Reporting Period:
- 2013-09-16
- Filing Date:
- 2013-09-17
- Accepted Time:
- 2013-09-17 17:37:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369786 | Sagent Pharmaceuticals Inc. | SGNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189013 | Jeffrey Yordon | C/O Sagent Pharmaceuticals, Inc. 1901 North Roselle Road, Suite 700 Schaumburg IL 60195 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-09-16 | 85,813 | $20.03 | 669,036 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- In connection with Sagent Pharmaceutical, Inc.'s (the "Issuer") registered offering, Jeffrey Yordon sold 85,813 shares of the Issuer's common stock, pursuant to an underwriting agreement, dated September 10, 2013, by and among the Issuer, the underwriters and the selling stockholders party thereto.
- Mr. Yordon's shares were sold at a price of $20.0282 per share, which is the price to the public ($21.25 per share) less the underwriting discounts and commissions ($1.2218 per share).
Billionaire Hedge Funds
